HiberGene -Group B Streptococcus (GBS)
Group B Streptococcus (GBS) – the only test for mother and baby. Saving time and saving money. Group B Streptococcus (GBS) is carried by 20-30% of pregnant women who risk transmitting the bacteria to the baby during birth, GBS is the leading cause of severe neonatal infection with high mortality (10%) and morbidity rates (20%)¹, Recent CDC and European guidelines recommend testing during labour using a rapid real time test to optimise antibiotic prophylaxis and prevent GBS infection²’³, Intrapartum testing is the only time that gives 100% certainty of GBS status, and can save up to 6$ per birth4
- Real-time, simple, intrapartum testing method
- Rapid results – Positive results in < 60 minutes during labour. Current culture methods can take up to 72 hrs and are not viable for intrapartum screening
- Rapid test for symptomatic newborns
The HG GBS test allows for antepartum GBS screening, intrapartum testing and testing for at risk or symptomatic new-borns to provide rapid and effective treatment of GBS.
Methodology: Loop Mediated Isothermal Amplification (LAMP)
Target: Streptococcus agalactiae
Sample types: Vaginal and rectal swab, Enriched Broth, CSF, Whole Blood
Hands-on time: = 10 minutes
Sample to result: = 60 minutes
| Product Name | # of Tests | Catalogue |
| HG Group B Streptococcus | 30 | HGGBSR |
| HG Group B Streptococcus Control | 18 | HGGBSC |
| HG Swift | – | HGSWIFT |
| HG Swift Plus | – | HG SWIFT PLUS STARTPCK |